Inherited predisposition to cancer: a historical overview.
The hereditary predisposition to cancer dates historically to interest piqued by physicians as well as family members wherein striking phenotypic features were shown to cluster in families, inclusive of the rather grotesque cutaneous findings in von Recklinghausen's neurofibromatosis, which date back to the sixteenth century. The search for the role of primary genetic factors was heralded by studies at the infrahuman level, particularly on laboratory mouse strains with strong susceptibility to carcinogen-induced cancer, and conversely, with resistance to the same carcinogens. These studies, developed in the 19th and 20th centuries, continue today. This article traces the historical aspects of hereditary cancer dealing with identification and ultimate molecular genetic confirmation of commonly occurring cancers, particularly of the colon in the case of familial adenomatous polyposis and its attenuated form, both due to the APC germline mutation; the Lynch syndrome due to mutations in mismatch repair genes, the most common of which were found to be MSH2, MLH1, and MSH6 germline mutations; the hereditary breast-ovarian cancer syndrome with BRCA1 and BRCA2 germline mutations; the Li-Fraumeni (SBLA) syndrome due to the p53 mutation; and the familial atypical multiple mole melanoma in association with pancreatic cancer due to the CDKN2A (p16) germline mutation. These and other hereditary cancer syndromes have been discussed in some detail relevant to their characterization, which, for many conditions, took place in the late 18th century and, in the more modern molecular genetic era, during the past two decades. Emphasis has been placed upon the manner in which improved cancer control will emanate from these discoveries.
Lynch
Henry T
HT
Department of Preventive Medicine, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA. htlynch@creighton.edu
Shaw
Trudy G
TG
Lynch
Jane F
JF
D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics / Q000266:history; D015179:Colorectal Neoplasms / Q000235:genetics / Q000266:history; D004195:Disease Models, Animal; D005260:Female; D020022:Genetic Predisposition to Disease; D049669:History, 16th Century; D049670:History, 17th Century; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008545:Melanoma / Q000235:genetics / Q000266:history; D051379:Mice; D009377:Multiple Endocrine Neoplasia / Q000235:genetics / Q000266:history; D009369:Neoplasms / Q000235:genetics / Q000266:history*; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics / Q000266:history; D017253:Neurofibromatoses / Q000235:genetics / Q000266:history; D010051:Ovarian Neoplasms / Q000235:genetics / Q000266:history; D010375:Pedigree